CY1109835T1 - Πυρανονες χρησιμες ως αναστολεις της atm - Google Patents

Πυρανονες χρησιμες ως αναστολεις της atm

Info

Publication number
CY1109835T1
CY1109835T1 CY20101100162T CY101100162T CY1109835T1 CY 1109835 T1 CY1109835 T1 CY 1109835T1 CY 20101100162 T CY20101100162 T CY 20101100162T CY 101100162 T CY101100162 T CY 101100162T CY 1109835 T1 CY1109835 T1 CY 1109835T1
Authority
CY
Cyprus
Prior art keywords
atm
suspensions
keywords used
sulfonamino
acylamido
Prior art date
Application number
CY20101100162T
Other languages
English (en)
Inventor
Graeme C M Smith
Niall Mb Martin
Stephen P Jackson
Connor Mark J O'
Alan Y K Lau
Xiao-Ling Fan Cockcroft
Ian Timothy Williams Matthews
Keith Allan Menear
Laurent Jean Martin Rigoreau
Marc Geoffrey Hummersone
Roger John Griffin
Original Assignee
Kudos Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0204350.3A external-priority patent/GB0204350D0/en
Application filed by Kudos Pharmaceuticals Limited filed Critical Kudos Pharmaceuticals Limited
Publication of CY1109835T1 publication Critical patent/CY1109835T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • AIDS & HIV (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η αίτηση αφορά μια ένωση του τύπου I: (I) όπου ένα από τα Ρ και Q είναι Ο, και το άλλο από τα Ρ και Q είναι Η, όπου υπάρχει ένας διπλός δεσμός μεταξύ οποιουδήποτε από τα Q και Ρ είναι CH και του ατόμου άνθρακα που φέρει την ομάδα R3· το Υ είναι είτε Ο είτε S· τα R1 και R2 είναι ανεξαρτήτως υδρογόνο, μια προαιρετικώς υποκατεστημένη C1-7 αλκυλο ομάδα, C3-20 ετεροκυκλυλο ομάδα, ή C5-20 αρυλο ομάδα, ή μαζί μπορούν να σχηματίσουν έναν προαιρετικώς υποκατεστημένο ετεροκυκλικό δακτύλιο που έχει από 4 έως 8 άτομα δακτυλίου· το R3 είναι μια φαινυλο ή πυριδυλο ομάδα, που συνδέεται με μια πρώτη ομάδα γέφυρας που επιλέγεται από -S-, -S(=O)-, -S(=O)2-, -Ο-, -NRN- και CRC1RC2- σε μια προαιρετικώς υποκατεστημένη C5-20 καρβοαρυλο ομάδα, όπου η φαινυλο ή πυριδυλο ομάδα και η προαιρετικώς υποκατεστημένη C5-20 καρβοαρυλο ομάδα προαιρετικώς συνδέονται περαιτέρω με μια δεύτερη ομάδα γέφυρας, έτσι ώστε να σχηματίσουν έναν προαιρετικώς υποκατεστημένο C5-7 δακτύλιο, όπου η φαινυλο ή πυριδυλο ομάδα είναι προαιρετικώς περαιτέρω υποκατεστημένη.
CY20101100162T 2002-02-25 2010-02-18 Πυρανονες χρησιμες ως αναστολεις της atm CY1109835T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0204350.3A GB0204350D0 (en) 2002-02-25 2002-02-25 ATM inhibitors
US39588402P 2002-07-15 2002-07-15
EP03742608A EP1485377B9 (en) 2002-02-25 2003-02-24 Pyranones useful as atm inhibitors

Publications (1)

Publication Number Publication Date
CY1109835T1 true CY1109835T1 (el) 2014-09-10

Family

ID=27758841

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100162T CY1109835T1 (el) 2002-02-25 2010-02-18 Πυρανονες χρησιμες ως αναστολεις της atm

Country Status (20)

Country Link
EP (2) EP2174939A1 (el)
JP (1) JP2005521689A (el)
CN (1) CN100358891C (el)
AT (1) ATE451365T1 (el)
AU (1) AU2003209990B8 (el)
BR (1) BR0307944A (el)
CA (1) CA2473100A1 (el)
CY (1) CY1109835T1 (el)
DE (1) DE60330442D1 (el)
DK (1) DK1485377T5 (el)
ES (1) ES2336206T3 (el)
GB (1) GB2401606B (el)
HK (1) HK1069827A1 (el)
MX (1) MXPA04007809A (el)
NO (1) NO329806B1 (el)
NZ (1) NZ534821A (el)
PL (1) PL370074A1 (el)
PT (1) PT1485377E (el)
SI (1) SI1485377T1 (el)
WO (1) WO2003070726A1 (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151102B2 (en) 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0119865D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119863D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
DE60335359D1 (de) 2002-04-30 2011-01-27 Kudos Pharm Ltd Phthalazinonderivate
US7122189B2 (en) 2002-08-13 2006-10-17 Enzon, Inc. Releasable polymeric conjugates based on aliphatic biodegradable linkers
US7413738B2 (en) 2002-08-13 2008-08-19 Enzon Pharmaceuticals, Inc. Releasable polymeric conjugates based on biodegradable linkers
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
WO2004097426A2 (en) * 2003-05-01 2004-11-11 Kudos Pharmaceuticals Limited Methods and means for the treatment of disorders associated with cellular senescence
WO2005016919A1 (en) 2003-08-13 2005-02-24 Kudos Pharmaceuticals Limited Aminopyrones and their use as atm inhibitors
DK2305221T3 (en) 2003-12-01 2015-08-24 Kudos Pharm Ltd DNA damage repair inhibitors for the treatment of cancer
WO2005118543A1 (ja) * 2004-06-03 2005-12-15 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
WO2006032869A1 (en) 2004-09-20 2006-03-30 Kudos Pharmaceuticals Limited Dna-pk inhibitors
JP2008529995A (ja) * 2005-02-09 2008-08-07 クドス ファーマシューティカルズ リミテッド Atm阻害剤
AR054438A1 (es) 2005-04-15 2007-06-27 Kudos Pharm Ltd Inhibidores de adn -pk
TW200745094A (en) * 2005-08-31 2007-12-16 Kudos Pharm Ltd ATM inhibitor
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
MX2010002749A (es) 2007-09-14 2010-06-25 Astrazeneca Ab Derivados de ftalazinona.
MX2011003740A (es) 2008-10-07 2011-05-02 Astrazeneca Uk Ltd Formulacion farmaceutica - 514.
EP2486923B1 (en) * 2011-02-11 2015-09-09 Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG Histone deacetylase (HDAC) inhibiting compounds and method of making same
KR20140147797A (ko) 2011-06-27 2014-12-30 더 잭슨 래보라토리 암 및 자가면역 질환의 치료 방법 및 조성물
WO2015030057A1 (ja) * 2013-08-29 2015-03-05 富士フイルム株式会社 新規なモルホリン誘導体またはその塩
CN116194109A (zh) 2020-06-24 2023-05-30 阿斯利康(英国)有限公司 抗体-药物缀合物和atm抑制剂的组合
CN112094210A (zh) * 2020-09-24 2020-12-18 江苏扬农化工股份有限公司 一种取代的亚磺酸盐的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282155A (en) * 1980-02-04 1981-08-04 Merck & Co., Inc. Antihypercholesterolemic compounds
EP0331250B1 (en) * 1988-03-02 1994-04-13 Merck & Co. Inc. Antihypercholesterolemic agents
DK0489877T3 (da) * 1990-06-29 1996-02-05 Upjohn Co Antiatherosklerotiske og antithrombotiske 2-amino-6-phenyl-4H-pyran-4-oner
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
WO1997043434A1 (fr) * 1996-05-14 1997-11-20 Snow Brand Milk Products Co., Ltd. Nouvelle substance active sur le plan physiologique et son procede de preparation
FR2765579A1 (fr) * 1997-07-01 1999-01-08 Lipha Nouveaux derives de 4-hydroxy-2h-1-(thio)pyran-2-ones leurs preparations et leurs utilisations comme rodonticides
ATE321035T1 (de) * 1997-09-26 2006-04-15 Toray Industries Zyklische ketonderivate und ihre pharmazeutische verwendung
ID27511A (id) * 1998-03-12 2001-04-12 Teijin Ltd Turunan-turunan benzofurilpiron

Also Published As

Publication number Publication date
WO2003070726A1 (en) 2003-08-28
ES2336206T9 (es) 2011-03-24
EP1485377B8 (en) 2010-02-24
NZ534821A (en) 2006-07-28
EP1485377B9 (en) 2010-10-06
GB2401606A (en) 2004-11-17
GB2401606B (en) 2005-08-31
CN100358891C (zh) 2008-01-02
CN1639154A (zh) 2005-07-13
MXPA04007809A (es) 2004-10-15
DK1485377T5 (da) 2010-12-06
CA2473100A1 (en) 2003-08-28
EP1485377B1 (en) 2009-12-09
GB0419534D0 (en) 2004-10-06
JP2005521689A (ja) 2005-07-21
ES2336206T3 (es) 2010-04-09
PL370074A1 (en) 2005-05-16
DK1485377T3 (da) 2010-04-19
EP2174939A1 (en) 2010-04-14
HK1069827A1 (en) 2005-06-03
NO329806B1 (no) 2010-12-20
ATE451365T1 (de) 2009-12-15
SI1485377T1 (sl) 2010-04-30
NO20044063L (no) 2004-09-24
EP1485377A1 (en) 2004-12-15
DE60330442D1 (de) 2010-01-21
PT1485377E (pt) 2010-03-12
AU2003209990B8 (en) 2008-10-30
BR0307944A (pt) 2005-02-01
AU2003209990A1 (en) 2003-09-09
AU2003209990B2 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
CY1109835T1 (el) Πυρανονες χρησιμες ως αναστολεις της atm
NO20061126L (no) Aminopyroner og deres anvendelse som ATM-inhibitorer
BR0316241A (pt) Pirrolobenzodiazepinas
ME00411B (me) Nova jedinjenja koja imaju inhibitorno dejstvo na transporter glukoze zavistan od natrijuma
HUP0301607A2 (hu) Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
RS51193B (sr) Hidantoinski derivati korisni kao inhibitori metaloproteinaza
DE68906183D1 (de) 2'-desoxy-5-fluoruridinderivate.
ATE457314T1 (de) Antibiotische spiroderivate
DK1086096T3 (da) Benzamider med tetrahydrofuranyloxy-substituenter som inhibitorer af phosphodiesterase 4
ATE111460T1 (de) 2-(aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre herstellung und ihre anwendung in der therapeutik.
HRP20020440B1 (en) 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
FI935798A0 (fi) Alkylsubstituerade heterocykliska foereningar
ATE266026T1 (de) Benzofurancarboxamide und deren therapeutische verwendung
WO2000008020A8 (en) Tricyclic carboxamides
ATE500243T1 (de) Carbonsäureamidverbindung und deren verwendung
NZ506908A (en) Cephalosporines having cyclic aminoguanidine substituents as antibiotics
ATE284379T1 (de) Aminderivate
IL178548A0 (en) Derivatives of 14,15-dihydro 20,21-dinoreburnamenin-14-ol, and applications thereof
ATE148462T1 (de) Isoxazole derivate als lichtschutzmittel